semaglutide medscape In a Danish nationwide study, just over half of adults without diabetes who started for weight loss discontinued within a year. Discontinuation was highest among younger adults (18–30 years), men, those Rat Medication:Tirzepatide (GLP-1 + GIP) Join us in Chicago

semaglutide medscape In a Danish nationwide study, just over half of adults without diabetes who started for weight loss discontinued within a year. Discontinuation was highest among younger adults (18–30 years), men, those Rat Medication:Tirzepatide (GLP-1 + GIP) Join us in Chicago

Join us in Chicago this November for “The Next Chapter of GLP-1,” an exclusive session at the GLP-1 Shopper Summit! Industry expert Sally Lyons Wyatt from @wearecircana will dive into groundbreaking research

Gastrointestinal effects Nausea is the most common tirzepatide side effect, affecting 12-18% of users in clinical trials

Rat

Medication:Tirzepatide (GLP-1 + GIP)

Physicians most frequently cited GI side effects—particularly persistent nausea and vomiting—as the primary reasons for discontinuation